Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous iron regimens with epoetin in anemia induced by radio-chemotherapy
2007-001325-96Phase 4Active
- Sponsor
- Pilar Samper Ots
- Start
- Mar 2010
- Modality
- Erythropoietins → Hormones & Growth Factors → Recombinant Proteins and Enzymes, Interleukins → Cytokines & Interferons → Recombinant Proteins and Enzymes, Colony Stimulating Factors → Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised trial of iron sucrose and epoetin beta in anaemia, bronchial carcinoma and head and neck cancer (HNC) (2 arms), sponsored by Pilar Samper Ots. Primary endpoint: Hemoglobin response rate. Started Mar 2010; status: active.
02
Drugs
iron sucroseepoetin beta
03
Conditions
anaemiabronchial carcinomahead and neck cancer (HNC)
Beyond the preview
Go deeper on 2007-001325-96.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-001325-96.